Retatrutide
GLP-1/GIP/Glucagon Agonist
Brand names: Retatrutide
Oral
Mechanism of Action
Triple incretin agonist targeting GLP-1, GIP, and glucagon receptors simultaneously for enhanced metabolic effects.
Indications
Obesity (Phase 3)
Type 2 Diabetes (Phase 3)
Known Side Effects
0 documented side effects by frequency
No structured side effect data available.
Community Discussions
No community discussions found for Retatrutide yet.
Compare With
0 available comparisons
No comparisons yet.
Formulations
Dosage Forms
Tablet
Route
Oral